Concepedia
Statistics
Publications
5
Citations
165
H-Index
Active since
2009
Affiliations
Gifu Pharmaceutical University(Current)
University of Shizuoka
Takasago (Japan)
Tomoki Sugiyama is an author at Gifu Pharmaceutical University specializing in pharmacology, stroke, and neuropharmacology.
Publications per year
2009–2020
A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapy
Yuki Murase, Tomohiro Asai, Yasufumi Katanasaka et al. · Cancer Letters · 2009 · 54 citations
Pharmacy, Medicinal Chemistry, Pharmacology +13
A novel Nrf2 activator, RS9, attenuates secondary brain injury after intracerebral hemorrhage in sub-acute phase
Tomoki Sugiyama, Takahiko Imai, Shinsuke Nakamura et al. · Brain Research · 2018 · 34 citations
Medicine, Neurology, Neuroscience +15
Enhanced Active Targeting via Cooperative Binding of Ligands on Liposomes to Target Receptors
Tomoki Sugiyama, Tomohiro Asai, Yuki Murase Nedachi et al. · PLoS ONE · 2013 · 32 citations · Full text
Pharmacy, Pharmaceutics, Pharmacology +17
Deferasirox, a trivalent iron chelator, ameliorates neuronal damage in hemorrhagic stroke models
Takahiko Imai, Shohei Tsuji, Hirohumi Matsubara et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2020 · 32 citations
Life Sciences, Neuroscience, Pharmacology +14
Levetiracetam, an Antiepileptic Drug has Neuroprotective Effects on Intracranial Hemorrhage Injury
Takahiko Imai, Tomoki Sugiyama, Sena Iwata et al. · Neuroscience · 2020 · 13 citations
Medicine, Neuroscience, Pharmacology +16
1–5 of 5